Journal of Haehwa Medicine (혜화의학회지)

Research Institute of Korean Medicine (대전대학교 한의학연구소)
권호 표지

Effects of Baedokhwanbalhyobang (BDHBH) on Immune Modulation in Dermatitis Model of NC/Nga Mice

배독환발효방(排毒丸醱酵方)의 면역조절작용을 통한 항아토피 효능

  • Gim, Seon-Bin (Department of Pathology, College of Oriental Medicine, Daejeon University) ;
  • Kim, Soo-Myung (Department of Anatomy, College of Oriental Medicine, Daejeon University) ;
  • Kim, Dong-Hee (Department of Pathology, College of Oriental Medicine, Daejeon University)
  • Received : 2011.01.10
  • Accepted : 2011.02.08
  • Published : 2011.02.20
Download PDF
⟨ Previous Next ⟩

Abstract

Herbal medicine has a high body absorption rate when it ferments. Biological and clinical research on the fermented herb gradually increases because it has effective materials for the treatment of a disease and it is a little bitter. In this study, we investigated the effect of fermented Baedokhwanbalhyobang (BDHBH) on attenuation of the development of atopic dermatitis in NC/Nga mice by evaluating the cytokine level in serum, the mRNA expression of cytokine and histological alteration of the skin, and the skin severity. We have come to the following conclusion. BDHBH led to a significant decrease in the skin severity score (63.1%) as compared to the control group. CD4+/CD45+, CD4+, B220+/CD23+, and CD11b+/Gr-1+cells of peripheral mononuclear cells (PBMCs) in the BDHBH-treated group were decreased to 6.7%, 31.1%, 22.4%, 36.6%, respectively. CD3+and CD11b+/Gr-1+immune cells in dorsal skin of the BDHBH-treated group were decreased to 52.9% and 28.0%. The levels of IL-5 and IL-13 in serum of the BDHBH-treated group were inhibited to 18.8% and 5.1%. The mRNA expressions of IL-5 and IL-13 in dorsal skin were also decreased to 30.6% and 27.8% after the treatment of BDHBH. BDHBH inhibited the proliferation and differentiation of eosinophils. In histological examination, BDHBH decreased the thickness of epidermis and dermis, and infilatration of mast cells as compared to the control group. These results indicate that BDHBH inhibits the pathogenic development of atopic dermatitis in NC/Nga mice. These results may indicate that BDHBH attenuates the development of atopic dermatitis-like lesions by lowering immune cells and inflammatory cytokine levels, and that it is valuable in drug development for the treatment of atopic dermatitis. Further experiments on the components of BDHBH will be needed to better understand the effect of a fermented herb as compared to a herb.

Keywords

References

  1. 신삼식 외. 아토피 피부염 환자에서 임상증상 및 가족력과 면역학적 검사의 상관관계. 대한피부과학회지, 1999;37(10):1399-1406.
  2. 김덕곤 외. 동의 소아과학. 정담, 2002;660-664.
  3. Sampson, H.A. : Atopic dermatitis, Ann Allergy, 1992;69(6):469-479.
  4. Daniels, et al. : The epidemiology of atopic dermatitis, Hosp Med, 2002;63(11):649-652.
  5. Shiohara T., et al. : Animal models for Atopic dermatitis: Are they relevant to human disease? Journal of Dermatological Science, 2004;36:1-9. https://doi.org/10.1016/j.jdermsci.2004.02.013
  6. Hoare C., et al. : Systematic review of treatment for atopic ecwema, Health Technol Assess, 2000;4(37):151-191.
  7. Yamamoto M., et al. : A novel atopic dermatitis model induced by topical application with dermatophagoides farinae extract in NC/Nga mice, Allergol Intern, 2007;56(2):139-148. https://doi.org/10.2332/allergolint.O-06-458
  8. 홍창의. 소아과학. 대한교과서(주), 1994;1066-1067.
  9. 박윤기 외. 흔히 보는 피부질환 진단과 치료. 고려의학, 1993;6-9.
  10. Howlett, S. : Emotional dysfunction, child-family relationships and childhood atopic dermatitis, Br J Dermatol, 1999;140(38):381-384.
  11. Lapidus, C. S., et al. : Social impact of atopic dermatitis. Med Health, 2001;84(9):294-295.
  12. Lewis-Jones, M. S., et al. : The children's dermatology life quality index : initial validation and practical use, Br J Dermatol, 1995;132(6):942-949.
  13. 이윤미 외. 학령전기와 학령기 아동에서의 아토피 피부염 유병률과 위험인자. 아동간호학회지, 2008;14(3):285-294.
  14. Barnetson, R. S. C., et al. : Childhood atopic eczema, BMJ, 324(7350):1376-1379.
  15. 이지현 외. 아토피피부염학회 보고서: 한국 아토피피부염의 치료지침. 대한피부과학회지, 2006;44(8):907-913.
  16. Brehler R., et al. : Recent developments in the treatment of atopic eczema, J Am Acad Dermatol, 1997;36:983-994. https://doi.org/10.1016/S0190-9622(97)80284-8
  17. Hanifin JM. : Atopic dermatitis, J Am Acad Dermatol, 1982;6:1-13. https://doi.org/10.1016/S0190-9622(82)70001-5
  18. Sampson HA. : Atopic dermatitis, Ann Allergy, 1992;69:469-481.
  19. 김상현. 한약의 효율성 개선을 위한 발효 한약 유용성에 관한 연구. 경기대학교대체의학대학원, 2008.
  20. 김용미. 발효한약의 연구동향 연구. 경원대학교대학원, 2009.
  21. 신용규 외.장수상황버섯과 마황을 이용한 고체 발효 추출물로부터 항아토피 활성의 분석. 한국식품저장유통학회, 2010;17(2):297-300.
  22. 손미예. 버섯균사체로 발효시킨 복령과 후박의 항산화 및 항암효과. 식품산업과 영양, 2007;12(2):51-57.
  23. 최재환 외. 구증구포 발효 한약 혼합물이 피부 노화에 미치는 영향. 대한본초학회지, 2009;24(4):101-106.
  24. 정윤혜. 황련 발효추출물의 항균효과 및 항산화활성에 관한 연구. 중부대학교대학원, 2010.
  25. 박경호. 白芷와 醱酵白芷의 성분 및 항염 활성 비교. 경희대학교대학원, 2007.
  26. 김시나 외. 갈근 추출물에 의한 염증성 Cytokine 생성 억제 및 Prostaglandin E2 활성 저해에 관한 연구. 한국식품영양과학회지, 2006;35(1):28-34.
  27. 김태희 외. 마황의 면역작용에 미치는 효과. 생약학회지, 1991;22(2):183-191.
  28. 박히준 외. 계지의 항염 효과에 관한 연구. 대한한의학회지, 2005;26(2):140-151.
  29. 박혜란 외. 당귀 물추출물의 면역증강 효과. 생명자원과 산업, 1998;3:80-88.
  30. 이양숙 외. 백지의 항산화성 및 생리기능. 한국식품영양과학회지, 2007;36(1):20-26.
  31. 류희중. 고정화 유산균에 의한 감초추출물의 유산발효 특성. 동국대학교대학원, 2006.
  32. 서설. 임상면역학. 고려의학, 2009;121-132.
  33. 김정원. 알레르기 및 면역학적 관점에서의 아토피피부염. 대한피부과학회지, 2003; 41(6):687-689.
  34. Soumelis V., et al. : Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP, Nat Immunol, 2002;3:673-680. https://doi.org/10.1038/nrm910
  35. Hamid Q., et al. : In vivo expression of IL-12 and IL-13 in atopic dermatitis, J Allergy Clin Immunol, 1996;98:225-231. https://doi.org/10.1016/S0091-6749(96)70246-4
  36. Mosmann T., et al. : Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties, Ann Rev Immunol, 1989;7:145-173. https://doi.org/10.1146/annurev.iy.07.040189.001045
  37. Wollenberg A., et al. : Atopic dermatitis: pathogenetic mechanisms, Clin Exp Dermatol, 2000;25:530-534. https://doi.org/10.1046/j.1365-2230.2000.00699.x
  38. Leung, D.Y.M. : Atopic dermatitis: new insights and opportunities for therapeutic intervention, J. Allergy Clin. immunol, 2000;105:860-876. https://doi.org/10.1067/mai.2000.106484
  39. Hill, P.B. et al. : The ACVD task force on canine atopic dermatitis (IV): environmental allergens, Vet Immunol Immunopathol, 2001;81(3-4):169-186. https://doi.org/10.1016/S0165-2427(01)00298-7
  40. Valenta, R., et al. : Autoallergy: a pathogenetic factor in atopic dermatitis? J Allergy Clin Immunol, 2000;105(3): 432-437. https://doi.org/10.1067/mai.2000.104783
  41. Mosmann T., et al. : Two types of mouse helper T-cell clone: Implications for immune regulation, Immunol Today, 1987;8:223-227. https://doi.org/10.1016/0167-5699(87)90171-X
  42. Romagnani S. : Immunologic influences on allergy and the Th1/Th2 balance, J Allergy Clin Immunol, 2004;113:395-400. https://doi.org/10.1016/j.jaci.2003.11.025
  43. 조기여. 피부과학. 성화, 2001;161-163.
  44. 강병수. 한방임상 알레르기. 성보사, 1988;196-201.
  45. Hill CJ., et al. : Adverse effects from topical steroids, Cutis, 1978;21:624-628.
  46. 이인규. 스테로이드 치료시 문제점. 대한내분비학회지, 1993;8(2):45-54.
  47. Reitamo S., et al. : Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis, J Allergy Clin Immunol, 2002;109:539-546. https://doi.org/10.1067/mai.2002.121831
  48. Reitamo S., et al. : Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis, J Allergy Clin Immunol, 2002;109:547-555. https://doi.org/10.1067/mai.2002.121832
  49. Cooper KD. : New therapeutic approaches in atopic dermatitis, Clin Rev Allergy, 1993;11:543-559.
  50. 김종수. 烏藥의 抗炎症 活性. 우석대학교 대학원, 2010.
  51. 은영준. 葛根 추출물이 항산화에 미치는 영향. 경원대학교대학원, 2007.
  52. 이옥희. 갈근 추출물이 흰쥐 혈액의 항산 화계에 미치는 영향. 자연과학연구소논문지, 2004;9(1):73-79.
  53. 배주연. LPS로 활성화된 복강 대식세포에서 麻黃이 配伍된 10種 처방의 NO 억제 효과. 원광대학교대학원, 2009.
  54. 이태현. 계지, 과체, 백자인의 항산화, 항염증, 미백 및 주름 억제 효과. 대전대학교 대학원, 2008.
  55. 서영남. 당귀의 감별 및 항산화 효능. 조선대학교대학원, 2004.
  56. 김종학. 백지 에틸 아세테이트 추출물의 항염증 효능 및 그 작용 기전에 관한 연구. 원광대학교대학원, 2009.
  57. 정성제 외. 약용 식물 추출물의 항산화 활성 검색. 한국응용생명화학회지, 2004; 47(1):135-140.
  58. 윤태호. 도인으로부터 항산화 물질의 생산과 특성. 배재대학교대학원, 2007.
  59. 김준한 외. 홍화씨 추출분말 함유 건강음료의 제조와 항산화성. 한국식품과학회지, 2002;34(4):617-624.
  60. Konji Matsushima, et al. : The NC/Nga mouse : a model for atopic dermatitis, Molecular medicine today, 2000; 6:209-210. https://doi.org/10.1016/S1357-4310(00)01683-X
  61. Shiohara T., et al. : Animal models for atopic dermatitis: are they relevant to human disease? J. Dermatol. Sci. 2004;36(1):1-9. https://doi.org/10.1016/j.jdermsci.2004.02.013
  62. Matsumoto M., et al. : IgE hyperproduction through enhanced tyrosine phosphorylation of Jauus kinase 3 in NC/Nga mice, a model for human atopic dermatitis, J. Immunol., 1999;162(2)1056-1063.
  63. Abul K., et al.. 최신면역학입문 3판. 이퍼블릭, 2009;pp.8-13.
  64. Abul K., et al.. 세포분자면역학 6판. 이퍼블릭, 2008;47-51,54-61.
  65. Wranke RA., et al. : Diagnosis of human lymphoma with monoclonal antileukocyte antibodies, New Engl J Med, 1983;309:1275-1281. https://doi.org/10.1056/NEJM198311243092102
  66. Kurtin PJ., et al. : Leukocyte common antigen recognized by a monoclonal antibody, Proc Natl Acad Sci, 1981;78:1791-1795. https://doi.org/10.1073/pnas.78.3.1791
  67. 이경일. 백혈구에서 CD45 분자의 역할. 소아과, 1996;39(12):1652-1660.
  68. 김정철 외. 한눈에 알 수 있는 면역학. 이퍼블릭, 2008;36-37.
  69. Dorshkind, K., et al. : Regulatory cells and cytokines involved in primary B lymphocyte production, Adv. Exp. Med. Biol, 1992;323:119-123.
  70. Getahun, A., et al. : IgE enhances antibody and T cell responses in vivo via CD23+ B cells, J Immunol, 2005;175(3):1473-1482.
  71. Li, Y.S., et al. : Identification of the earliest B lineaga stage in mouse bone marrow, Immunity, 1996;5(6):527-535. https://doi.org/10.1016/S1074-7613(00)80268-X
  72. Sancho D., et al. : CD69 is an immunoregulatory molecule induced following activation, Trends Immunol, 2005;26:136-140. https://doi.org/10.1016/j.it.2004.12.006
  73. Dorshkind K., et al. : Regulatory cells and cytokines involved in primary B lymphocyte production, Adv Exp Med Biol, 1992;323:119-123.
  74. Klemm, S., et al. : The Bcl10-Malt1 complex segregates Fc epsilon RI-mediated nuclear factor kappa B activation and cytokine production from mast cell degranulation, J Exp Med, 2006;203(2):337-347. https://doi.org/10.1084/jem.20051982
  75. Cho, S.H., et al. : Protein kinase Cdelta functions downstream of Ca2+ mobilization in FcepsilonRI signaling to degranulation in mast cells, J Allergy Clin Immunol, 2004;114(5):1085-1092. https://doi.org/10.1016/j.jaci.2004.07.035
  76. 高弘胤. 아토피피부염에 대한 苦參加味方과 淸肌解毒散의 倂用 投與 效果. 대전대학교대학원, 2010.
  77. 方瓚國. 補陰祛風止痒湯이 아토피 피부염을 誘導한 NC/Nga 생쥐 모델에서의 免疫調節 作用. 대전대학교대학원, 2008.
  78. 河如泰. 內外治 兼用法의 아토피 피부염 활용에 관한 실험적 연구. 대전대학교대학원, 2009.
  79. Bonifacino JS., et al. : The T-cell antigen receptor: a complex signal-transducing molecule, Princess Takamatsu Symp, 1988;19:87-104.
  80. 김세종 : 면역학, 고려의학, 1994;74-81.
  81. Bos, J.D. : Atopiform dermatitis, Br J Dermatol, 2002;147(3):426-429. https://doi.org/10.1046/j.1365-2133.2002.05010.x
  82. Schmid-Grendelmeier, P., et al. : Epidemiology, clinical features, and immunology of the "intrinsic" (non-IgE-mediated) type of atopic dermatitis (constitutional dermatitis), Allergy, 2001;56(9):841-849. https://doi.org/10.1034/j.1398-9995.2001.00144.x
  83. Johansson, S.G., et al. : A revised nomenclature for allergy. An EAACI position statement form the EAACI nomenclature task force, Allergy, 2001;56(9):813-824. https://doi.org/10.1034/j.1398-9995.2001.t01-1-00001.x
  84. Folster-Holst, R., et al. : Low prevalence of the intrinsic form of atopic dermatitis among adult patients, Allergy, 2006;61(5):629-632. https://doi.org/10.1111/j.1398-9995.2006.01076.x